8-K
File 000-56600
CURRENT REPORT
- Filing date
- 12 Mar 2024
- Reporting date
- 08 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
Ambrx Biopharma, Inc. reports
- Company location
- La Jolla, CA
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
Ambrx Biopharma, Inc. has filed 77 SEC EDGAR filings since 25 Aug 2023
SEC filing history
Showing 1-8 of 8 matching filings.
Per page
25
Current page
1
8-K
File 000-56600
8-K
- Filing date
- 07 Mar 2024
- Reporting date
- 07 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 06 Mar 2024
- Reporting date
- 06 Mar 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 22 Feb 2024
- Reporting date
- 21 Feb 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 08 Jan 2024
- Reporting date
- 05 Jan 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 01 Dec 2023
- Reporting date
- 01 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 23 Oct 2023
- Reporting date
- 22 Oct 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
8-K
File 000-56600
8-K
- Filing date
- 16 Oct 2023
- Reporting date
- 16 Oct 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing